Literature DB >> 17581534

Methylphenidate enhances the abuse-related behavioral effects of nicotine in rats: intravenous self-administration, drug discrimination, and locomotor cross-sensitization.

Thomas E Wooters1, Nichole M Neugebauer, Craig R Rush, Michael T Bardo.   

Abstract

Stimulant drugs, including D-amphetamine, cocaine, and methylphenidate, increase cigarette smoking in controlled human laboratory experiments. Although the mechanism(s) underlying this effect are unknown, it is possible that stimulants may enhance directly the abuse-related effects of nicotine. In the present study, we characterized the behavioral pharmacological interactions between methylphenidate and nicotine in the intravenous self-administration, drug discrimination, and locomotor cross-sensitization procedures. Adult male Sprague-Dawley rats were trained to respond for intravenous nicotine (0.01 or 0.03 mg/kg/infusion) or sucrose, and the acute effects of methylphenidate (1.25-10 mg/kg) were determined; in addition, separate groups of rats were treated with methylphenidate (2.5 mg/kg) or saline before 12 consecutive nicotine (0.03 mg/kg/infusion) self-administration sessions. Next, the discriminative stimulus effects of nicotine (0.03-0.3 mg/kg) and methylphenidate (1.25-10 mg/kg), alone and in combination with a low nicotine dose (0.056 mg/kg), were tested in nicotine-trained rats. Finally, the locomotor effect of repeated methylphenidate (2.5 mg/kg) was tested in rats previously treated with nicotine (0.2-0.8 mg/kg). Results indicated that acute methylphenidate increased the rate of nicotine self-administration at doses that reduced sucrose-maintained responding; furthermore, tolerance to this effect was not apparent following repeated methylphenidate. Methylphenidate, while not substituting for nicotine alone, dose-dependently enhanced the discriminative stimulus effect of a low nicotine dose. In addition, repeated nicotine exposure promoted the development of locomotor sensitization to methylphenidate. Taken together with recent clinical findings, these results suggest that methylphenidate may enhance the abuse-related behavioral effects of nicotine, perhaps increasing vulnerability to tobacco dependence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17581534      PMCID: PMC2664110          DOI: 10.1038/sj.npp.1301477

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  79 in total

Review 1.  Drugs of abuse and the brain.

Authors:  A I Leshner; G F Koob
Journal:  Proc Assoc Am Physicians       Date:  1999 Mar-Apr

Review 2.  Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking.

Authors:  J E Rose; E D Levin
Journal:  Br J Addict       Date:  1991-05

3.  The acquisition of responding with conditioned reinforcement: effects of pipradrol, methylphenidate, d-amphetamine, and nomifensine.

Authors:  T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1978-06-15       Impact factor: 4.530

4.  d-amphetamine increases choice of cigarette smoking over monetary reinforcement.

Authors:  J W Tidey; S C O'Neill; S T Higgins
Journal:  Psychopharmacology (Berl)       Date:  2000-12       Impact factor: 4.530

5.  Asymmetric generalization between the discriminative stimulus effects of nicotine and cocaine.

Authors:  R I Desai; D J Barber; P Terry
Journal:  Behav Pharmacol       Date:  1999-11       Impact factor: 2.293

6.  Nicotine maintains robust self-administration in rats on a limited-access schedule.

Authors:  W A Corrigall; K M Coen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Chronic nicotine differentially alters cocaine-induced locomotor activity in adolescent vs. adult male and female rats.

Authors:  Stephanie L Collins; Sari Izenwasser
Journal:  Neuropharmacology       Date:  2004-03       Impact factor: 5.250

Review 8.  Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.

Authors:  Joseph Biederman; Thomas Spencer; Timothy Wilens
Journal:  Int J Neuropsychopharmacol       Date:  2004-01-21       Impact factor: 5.176

9.  Cigarette smoking and subjective response: effects of d-amphetamine.

Authors:  J E Henningfield; R R Griffiths
Journal:  Clin Pharmacol Ther       Date:  1981-10       Impact factor: 6.875

10.  Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.

Authors:  Dawn D Han; Howard H Gu
Journal:  BMC Pharmacol       Date:  2006-03-03
View more
  17 in total

Review 1.  Neuropharmacology of the interoceptive stimulus properties of nicotine.

Authors:  Thomas E Wooters; Rick A Bevins; Michael T Bardo
Journal:  Curr Drug Abuse Rev       Date:  2009-09

Review 2.  Nicotine reduction revisited: science and future directions.

Authors:  Dorothy K Hatsukami; Kenneth A Perkins; Mark G Lesage; David L Ashley; Jack E Henningfield; Neal L Benowitz; Cathy L Backinger; Mitch Zeller
Journal:  Tob Control       Date:  2010-10       Impact factor: 7.552

3.  Methylphenidate and fluphenazine, but not amphetamine, differentially affect impulsive choice in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats.

Authors:  Thomas E Wooters; Michael T Bardo
Journal:  Brain Res       Date:  2011-05-01       Impact factor: 3.252

Review 4.  Interactions between nicotine and drugs of abuse: a review of preclinical findings.

Authors:  Stephen J Kohut
Journal:  Am J Drug Alcohol Abuse       Date:  2016-09-02       Impact factor: 3.829

5.  Nicotine drug discrimination and nicotinic acetylcholine receptors in differentially reared rats.

Authors:  Charles S Bockman; Wanyun Zeng; Jamie Hall; Beth Mittelstet; Liz Schwarzkopf; Dustin J Stairs
Journal:  Psychopharmacology (Berl)       Date:  2018-02-21       Impact factor: 4.530

6.  The influence of smoking cigarettes on the high and desire for cocaine among active cocaine users.

Authors:  Alex J Brewer; James J Mahoney; Chandra S Nerumalla; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Biochem Behav       Date:  2013-03-27       Impact factor: 3.533

7.  Nicotine and amphetamine acutely cross-potentiate their behavioral and neurochemical responses in female Holtzman rats.

Authors:  Emily M Jutkiewicz; Danielle M Nicolazzo; Myung N Kim; Margaret E Gnegy
Journal:  Psychopharmacology (Berl)       Date:  2008-06-20       Impact factor: 4.530

8.  Gabapentin for smoking cessation.

Authors:  Amit Sood; Jon O Ebbert; Kirk D Wyatt; Ivana T Croghan; Darrell R Schroeder; Richa Sood; J Taylor Hays
Journal:  Nicotine Tob Res       Date:  2010-01-15       Impact factor: 4.244

9.  Reinstatement of methamphetamine conditioned place preference in nicotine-sensitized rats.

Authors:  Jennifer N Berry; Nichole M Neugebauer; Michael T Bardo
Journal:  Behav Brain Res       Date:  2012-08-04       Impact factor: 3.332

10.  Nicotinic receptors differentially modulate the induction and expression of behavioral sensitization to methylphenidate in rats.

Authors:  Thomas E Wooters; Michael T Bardo
Journal:  Psychopharmacology (Berl)       Date:  2009-02-20       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.